Home › Cancer (all types) › NCT06207864
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Participant Engagement - Cancer Genome Sequencing (PE-CGS) Research Center: Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * The PE-CGS Research Center is only recruiting and sequencing tumors for adult-onset cancers (patients and survivors) among the American Indian Tribes, Nations, and Pueblos of New Mexico and adjacent states * Male or female adults (18 years) or older * Cancer patient undergoing active treatment or a cancer survivor * Self-identify as American Indian Exclusion Criteria: * Cognitively impaired * Adults unable to consent for themselves * Individuals who are not yet adults * Prisoners
About the study
This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.
What is being tested
- Biospecimen Collection (procedure)
- Return of Results (procedure)
- Survey Administration (other)
Sponsor: New Mexico Cancer Research Alliance · Participants: 1,001 · Started: Mar 22, 2022
Contact the study team
- Andrew Sussman, PhD · Phone: (505) 272-4077
- Kelsey Ayers, BS · Phone: 1-833-795-0464
Official record on ClinicalTrials.gov — NCT06207864
Locations in the U.S.
| New Mexico | University of New Mexico Comprehensive Cancer Center, Albuquerque |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.